GetPortalImpactFactorByIdResp(projectId=1, id=51b42389, cover=https://img.medsci.cn/images/journal/cover/2021/ous_202109271315017870.jpg, fullname=EXPERT OPINION ON THERAPEUTIC PATENTS, abbr=EXPERT OPIN THER PAT, pyear=1994, frequence=Monthly, articleNumbers=677, citedSelf2015=2.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1354-3776, greenSci=https://www.greensci.net/search?kw=1354-3776, scijournal=https://www.scijournal.org/impact-factor-of-EXPERT-OPIN-THER-PAT.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.747, medsciHotlight=1.982, medsciHotlight5year=2.47736, citescore=9.8, hIndex=71, impactFactor=6.6, orgnization=Taylor and Francis Ltd., orgnizationUrl=http://www.informapharmascienc, country=United Kingdom, countryCn=英国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded|Current Contents - Life Sciences, bigclassCas=医学 3区, smallclassCas=医学 2 区, website=https://www.tandfonline.com/loi/ietp20#.V48csUz9cSQ, websiteHits=5427, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=https://mc.manuscriptcentral.com/eotp, submitWebsiteHits=1586, content=Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3776.<br /><br />Expert Opinion on Therapeutic Patents (EOTP) (ISSN 1354-3776) is published monthly and is the leading patent journal for pharmaceutical patent information. Expert Opinion on Therapeutic Patents provides a monthly, peer-reviewed guide to the technological advances and developments in pharmaceutical patents. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than to simply review the available data. Each issue of the journal contains annotated patent selections and short patent evaluations which highlight inventions and innovative ideas deemed by relevant experts to be of potential importance. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Therapeutic Patents adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas., totalCites=4472, brief=EXPERT OPIN THER PAT杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=医学：法" >医学：法</a></strong>”子行业的中等级别杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=EXPERT OPIN THER PAT在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=51b42389'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.75), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.88), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.31), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=9.8)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.414), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.874), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.687), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.793), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.747)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Drug Discovery , rank=15/143), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology , rank=33/301)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=CHEMISTRY , rank=4/61), GetImpactFactorCiteScoreGradeResponse(smallClass=MEDICINAL - SCIE , rank=), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY - SCIE , rank=20/270)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3776[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Expert Opinion on Therapeutic Patents[ta], article_number=64, article_number_cn=25, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)